Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Invested Capital (2016 - 2025)

OptimizeRx (OPRX) has disclosed Invested Capital for 16 consecutive years, with $154.6 million as the latest value for Q4 2025.

  • Quarterly Invested Capital rose 2.18% to $154.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $154.6 million through Dec 2025, up 2.18% year-over-year, with the annual reading at $154.6 million for FY2025, 2.18% up from the prior year.
  • Invested Capital hit $154.6 million in Q4 2025 for OptimizeRx, up from $151.1 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $164.8 million in Q4 2023 to a low of $115.8 million in Q2 2023.
  • Historically, Invested Capital has averaged $133.8 million across 5 years, with a median of $128.2 million in 2021.
  • Biggest five-year swings in Invested Capital: skyrocketed 186.59% in 2021 and later decreased 17.76% in 2023.
  • Year by year, Invested Capital stood at $131.4 million in 2021, then fell by 4.01% to $126.1 million in 2022, then skyrocketed by 30.71% to $164.8 million in 2023, then dropped by 8.22% to $151.3 million in 2024, then grew by 2.18% to $154.6 million in 2025.
  • Business Quant data shows Invested Capital for OPRX at $154.6 million in Q4 2025, $151.1 million in Q3 2025, and $148.6 million in Q2 2025.